Although today’s PR is positive, it doesn’t address the market’s #1 concern - cash on hand (IMO). Despite B-ABSSSI’s excellent data, investors saw Phase 3 put on hold for two years due to lack of cash. We know it’s not Leo’s fault but the stock won’t get any sympathy from the market.
I have no doubt that Leo will be able to get a deal with large upfront payment for B-OM. Once the cash concern is resolved, the stock will fly. I know what I said isn’t popular here, so fire away.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links